Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AEterna focuses Neovastat program on NSCLC

Dec. 19, 2003

Pixantrone shows antitumor efficacy in relapsed/refractory NHL

Dec. 19, 2003

Clinical benefits of gene therapy with Ad-CD154 for CLL

Dec. 19, 2003

Novel HDAC inhibitors idenified at AstraZeneca

Dec. 19, 2003

New tyrosine kinase inhibitors, their preparation and use covered by Merck patent

Dec. 19, 2003

Sosei and Nippon Organon to copromote SOT-375 in Japan

Dec. 18, 2003

Efficacy and safety of lonafarnib in hematological tumors

Dec. 18, 2003

Antitumor effects of CCI-779 in multiple myeloma and MCL

Dec. 18, 2003

Phase I trial of topotecan TCS delayed until Q3 2004

Dec. 18, 2003

New findings on structure and function of prostate-specific membrane antigen

Dec. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...